跳至主要内容
临床试验/NCT05272618
NCT05272618招募中不适用

Clinical Relevance of Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With Non-Obstructive Coronary Arteries

Chonnam National University Hospital2 个研究点 分布在 2 个国家目标入组 150 人开始时间: 2022年2月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
2
主要终点
MACCE

研究概览

简要总结

To compare clinical outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA) according to the coronary microvascular dysfunction (CMD), evaluated by optical coherence tomography (OCT), invasive and non-invasive coronary physiologic assessment.

详细描述

Background Approximately 5~10% of patients with acute myocardial infarction (AMI) have been reported as myocardial infarction with non-obstructive coronary arteries (MINOCA) in the contemporary clinical setting. Although those with MINOCA have a better prognosis than with obstructive coronary artery disease, several observational studies continuously reported that patients with MINOCA showed comparable outcomes. One plausible explanation of this discrepancy is the heterogeneous and variable definition of MINOCA. Possible causes of MINOCA include plaque erosion and/or rupture, vasospasm, and CMD. Therefore, it is natural that heterogeneous pathophysiology of MINOCA causes diagnostic challenges and proper management.

Recently, there have been efforts for establishing the diagnosis of MINOCA and standardizing the systematic management according to the cause of MINOCA. According to the AHA scientific statement, patients who suspected MINOCA have been recommended to perform multimodality approach, including intravascular imaging (i.e., OCT). Although non-invasive methods, such as N-13 ammonia positron emission tomography (PET), can be used for evaluating the CMD, invasive coronary physiologic assessment using pressure-temperature wire has been recommended. CMD has been known as a major cause of MINOCA, and it may be required specific treatment.

Nevertheless, there has no data on the outcomes of MINOCA with or without CMD. Therefore, the aim of CMD-MINOCA sought to assess the MINOCA patients regarding the latest clinical pathway for diagnosis of CMD and evaluate their clinical outcomes at 2 years.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject with age ≥19 years and acute myocardial infarction
  • Rise and/or fall of cardiac troponin with one level >99 percentile plus ischemic signs/symptoms
  • Subject with non-obstructive coronary arteries
  • <50% diameter stenosis or
  • fractional flow reserve (FFR) >0.80 ③ Subject without previous history of coronary artery disease
  • Subject who performed invasive coronary angiography within 24 hours after presentation ⑤ Subject who eligible for invasive and non-invasive coronary physiologic assessment

排除标准

  • Subject with obstructive coronary arteries
  • Subject with alternate diagnosis including sepsis, pulmonary embolism, myocarditis, Takotsubo syndrome, spontaneous coronary dissection, and other cardiomyopathies.
  • Subject with cardiogenic shock or cardiac arrest ④ Subject who has non-cardiac co-morbid conditions with life expectancy <1 year ⑤ Subject or lactating women ⑥ Subject unable to provide consent

研究组 & 干预措施

MINOCA with CMD

MINOCA patients with CMD proven by invasive or non-invasive method

干预措施: Intravascular imaging (OCT), Invasive physiologic assessment (FFR, CFR, IMR), or Non-invasive physiologic assessment (N-13 ammonia PET) (Diagnostic Test)

MINOCA without CMD

MINOCA patients without CMD

干预措施: Intravascular imaging (OCT), Invasive physiologic assessment (FFR, CFR, IMR), or Non-invasive physiologic assessment (N-13 ammonia PET) (Diagnostic Test)

结局指标

主要结局

MACCE

时间窗: 2-Year after enrollment

a composite of cardiac death, any MI, any revascularization, stroke, readmission due to heart failure

次要结局

  • cardiac death(2-Year after enrollment)
  • re-admission due to heart failure(2-Year after enrollment)
  • all-cause death, any MI, or any revascularization(2-Year after enrollment)
  • Changes of left ventricular ejection fraction(2-Year after enrollment)
  • Rate of myocardial infarction(2-Year after enrollment)
  • Changes of Coronary flow reserve(6-Month after enrollment)
  • Rate of stroke(2-Year after enrollment)
  • Rate of repeat revascularization(2-Year after enrollment)
  • all-cause death(2-Year after enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Young Joon Hong

Professor

Chonnam National University Hospital

研究点 (2)

Loading locations...

相似试验